Medicare Enrolled
Dr. Glenn Parris, M.D.
Optician · Lawrenceville, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Parris from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Parris?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Parris
Dr. Glenn Parris is an optician specialist in Lawrenceville, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Parris performed 131,666 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Parris received a total of $38,771 from 52 pharmaceutical and/or device companies across 1450 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Parris is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 1% volume in GA
$38,771 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗131,666
Medicare services
Top 1% in GA for optician
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 45,296 | $5 | $8 |
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
44,400 | $4 | $13 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
16,208 | $10 | $18 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
11,251 | $33 | $78 |
| Denosumab injection (Prolia/Xgeva) | 8,460 | $18 | $35 |
| Infliximab-abda biosimilar injection, 10 mg This code represents the administration of a 10 mg dose of infliximab-abda, a biosimilar medication. It covers the injection of this specific pharmaceutical product. |
2,650 | $29 | $124 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
670 | $63 | $184 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
362 | $90 | $270 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
348 | $11 | $64 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
325 | $51 | $270 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
322 | $12 | $85 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
245 | $4 | $60 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
217 | $102 | $550 |
| Complete ultrasound scan of joint An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures. |
125 | $40 | $185 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
121 | $53 | $175 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
111 | $22 | $375 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
99 | $1 | $15 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
96 | $3 | $20 |
| X-ray of hand, 2 views An X-ray imaging test of the hand using two different angles to visualize the bones and joints. |
60 | $25 | $65 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
50 | $118 | $415 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
37 | $4 | $20 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
36 | $30 | $88 |
| X-ray of foot, 2 views An X-ray imaging test of the foot using two different angles to create pictures of the bones and joints. |
36 | $23 | $65 |
| Bone density scan (DEXA) of hip, pelvis, and spine This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures. |
36 | $51 | $102 |
| Knee X-ray, 1-2 views An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures. |
30 | $28 | $75 |
| X-ray of upper spine, 2-3 views An X-ray imaging test of the upper spine using two to three different angles to visualize the bones and structures. |
19 | $30 | $83 |
| X-ray of shoulder, 1 view An X-ray image of the shoulder joint taken from a single angle. This imaging test is used to visualize the bones and surrounding structures of the shoulder. |
16 | $17 | $49 |
| Injection, methylprednisolone acetate, 40 mg | 16 | $6 | $30 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
13 | $40 | $155 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $82 | $273 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
21.3% high complexity
77.7% medium
1.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$38,771
Total received (2018-2024)
Avg $5,539/year across 7 years
Top 4% in GA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
1,450
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,505
2023
$8,470
2022
$5,605
2021
$11,175
2020
$2,567
2019
$3,511
2018
$1,939
Payments by company (2024)
ABBVIE INC.
$1,530
Amgen Inc.
$991
Janssen Biotech, Inc.
$840
UCB, Inc.
$448
Novartis Pharmaceuticals Corporation
$234
GlaxoSmithKline, LLC.
$229
Mallinckrodt Hospital Products Inc.
$229
PFIZER INC.
$194
GENZYME CORPORATION
$160
Aurinia Pharma U.S., Inc.
$79
Radius Health, Inc.
$75
Octapharma USA, Inc.
$70
E.R. Squibb & Sons, L.L.C.
$59
SOBI, INC
$56
Sandoz Inc.
$48
Cardinal Health Inc
$43
Organon Llc
$40
Actelion Pharmaceuticals US, Inc.
$38
Kiniksa Pharmaceuticals International, plc
$31
Eisai Inc.
$26
AstraZeneca Pharmaceuticals LP
$24
ANI Pharmaceuticals, Inc.
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
SCILEX PHARMACEUTICALS INC.
$17
Top 3 companies account for 61.1% of 2024 payments
All-time payments by company (2018-2024) ›
Horizon Therapeutics plc
$9,559
UCB, Inc.
$4,847
ABBVIE INC.
$4,602
Amgen Inc.
$3,028
Janssen Biotech, Inc.
$2,005
AbbVie Inc.
$1,677
Novartis Pharmaceuticals Corporation
$1,637
Mallinckrodt Hospital Products Inc.
$1,370
GENZYME CORPORATION
$1,177
GlaxoSmithKline, LLC.
$1,098
PFIZER INC.
$956
AstraZeneca Pharmaceuticals LP
$826
E.R. Squibb & Sons, L.L.C.
$739
AbbVie, Inc.
$720
Aurinia Pharma U.S., Inc.
$554
NOVARTIS PHARMACEUTICALS CORPORATION
$497
Lilly USA, LLC
$492
Boehringer Ingelheim Pharmaceuticals, Inc.
$482
Horizon Pharma plc
$265
Octapharma USA, Inc.
$196
Genentech USA, Inc.
$193
MEDEXUS PHARMA, INC.
$164
Organon LLC
$161
Mallinckrodt Enterprises LLC
$161
Alexion Pharmaceuticals, Inc.
$150
Celgene Corporation
$144
Janssen Scientific Affairs, LLC
$121
Radius Health, Inc.
$103
Regeneron Healthcare Solutions, Inc.
$99
Sandoz Inc.
$69
Mallinckrodt LLC
$67
SOBI, INC
$56
Actelion Pharmaceuticals US, Inc.
$55
Merck Sharp & Dohme Corporation
$49
Eisai Inc.
$49
Cardinal Health Inc
$43
Takeda Pharmaceuticals U.S.A., Inc.
$42
Organon Llc
$40
TerSera Therapeutics LLC
$32
Kiniksa Pharmaceuticals International, plc
$31
BOSTON SCIENTIFIC CORPORATION
$24
ANI Pharmaceuticals, Inc.
$24
Kiniksa Pharmaceuticals, Ltd.
$21
CSL Behring
$21
Ultragenyx Pharmaceutical Inc.
$19
Sobi, Inc
$17
SCILEX PHARMACEUTICALS INC.
$17
MEDAC PHARMA, INC.
$15
ARBOR PHARMACEUTICALS, INC.
$15
Zyla Life Sciences
$15
Hikma Pharmaceuticals USA
$15
Fresenius Kabi USA, LLC
$14
Top 3 companies account for 49.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · Cimzia · Dayvigo · EVENITY · EVUSHELD · Enbrel · FORTEO · GLOPERBA · HADLIMA · HUMIRA · HYQVIA · HYRIMOZ · Hizentra · Horizant · Humira · IDACIO · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Leqembi · Mitigare · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · Otezla · PRIALT · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SOLIRIS · SPRIX · STELARA · STRENSIQ · Strensiq · Superion · TALTZ · TAVNEOS · TEPEZZA · TREMFYA · Tavneos · Tymlos · UPTRAVI · WAINUA · XELJANZ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Opticians in nearby ZIP areas
518
County median income
$84,823
Nearest hospital to ZIP centroid (approximate)
SUMMITRIDGE CENTER- PSYCHIATRY & ADDICTIVE MED
4.7 mi
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Parris is a mixed practice specialist, with above-average Medicare volume (top 1% in GA), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Parris experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Parris performed 45,296 tocilizumab injection (actemra) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Parris receive payments from pharmaceutical companies?
Yes. Dr. Parris received a total of $38,771 from 52 companies across 1,450 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Parris's costs compare to other opticians in Lawrenceville?
Dr. Parris's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Parris) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Lawrenceville
Browse opticians in Lawrenceville ranked by procedure volume and transparency data.
Highest volume
Top Opticians in GA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in GA
Which GA opticians receive the most from drug and device companies.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology